Jiawei Shoutai Pill promotes embryo implantation via PPAR signaling and endometrial microbiota remodeling: An integrative multi-omics study
Phytomedicine · 2026-08 · 158 · 158296
DOI: 10.1016/j.phymed.2026.158296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-08. Verfasst von Yi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Embryo Implantation, Drugs, Chinese Herbal, Endometrium, Peroxisome Proliferator-Activated Receptors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: China Scholarship Council, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND: Recurrent implantation failure (RIF) remains a major barrier to successful assisted reproductive technology, given the lack of effective, mechanism-informed interventions to enhance endometrial receptivity. Jiawei Shoutai Wan (pills) (JWSTW), a modified formulation of the classic Shoutai Pill (STP) used in reproductive medicine, has not been systematically evaluated in the treatment of RIF, and its bioactive components and molecular targets remain largely unclear. PURPOSE: To determine whether JWSTW improves implantation competence and to identify the pathways associated with its effects. MATERIALS AND METHODS: A mifepristone-induced embryo implantation dysfunction (EID) rat model was established to evaluate implantation outcomes, uterine histology, and markers of endometrial receptivity and vascular perfusion. Bulk uterine transcriptomics and peripheral blood serum untargeted metabolomics were integrated with liquid chromatography-tandem mass spectrometry (LC-MS) based component profiling, network pharmacology, multi-omics correlation analysis, uterine cavity microbiota profiling and structure-based computational analyses. Key pathway molecules were further assessed using targeted molecular experiments. A retrospective cohort of RIF patients undergoing assisted reproduction was analyzed for ultrasound-derived endometrial receptivity parameters before and after treatment. RESULTS: JWSTW administration improved implantation outcomes in EID rats, characterized by the upregulation of multiple receptivity- and perfusion-associated tissue markers. Integrated multi-omics analyses identified peroxisome proliferator-activated receptor (PPAR) signaling and lipid metabolism as significantly enriched pathways, supported by corresponding gene-metabolite correlations. Animal experiments using PPAR agonists (rosigitazone) and antagonists (T0070907) further confirmed that the PPAR pathway is a primary target of JWSTW. JWSTW was also associated with structured changes in the uterine cavity microbiota, with enriched taxa and predicted functions aligned with lipid metabolism related pathways. LC-MS/MS characterization identified sweroside and loganic acid as major circulating constituents, while computational analyses prioritized a PPAR-centered target network with favorable binding affinity and structural stability. In the retrospective RIF cohort (n = 100), JWSTW was associated with increased endometrial thickness and improved Doppler-derived perfusion indices. CONCLUSION: These results demonstrated that JWSTW enhances endometrial receptivity and promotes embryo implantation in RIF by modulating the PPAR-lipid metabolism axis and remodeling the uterine microbiota. Consequently, our study advances the pharmacodynamic understanding of JWSTW and deepens the comprehension of its underlying mechanistic basis in RIF. Furthermore, these findings provide an innovative Traditional Chinese Medicine-based treatment strategy, offering a promising therapeutic avenue for patients with RIF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
- Reproductive Center of Integrated Medicine, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China; The First Clinical College, Shandong University of Traditional Chinese Medicine,…
Förderung
- China Scholarship Council
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- China Postdoctoral Science Foundation
Zitieren
APA
Zhang, Y., Cao, X., Ma, Y., Guo, Z., Lian, F., Song, J., & Sun, Z. (2026). Jiawei Shoutai Pill promotes embryo implantation via PPAR signaling and endometrial microbiota remodeling: An integrative multi-omics study. Phytomedicine, 158, 158296. https://doi.org/10.1016/j.phymed.2026.158296
Vancouver
Zhang Y, Cao X, Ma Y, Guo Z, Lian F, Song J, et al. Jiawei Shoutai Pill promotes embryo implantation via PPAR signaling and endometrial microbiota remodeling: An integrative multi-omics study. Phytomedicine. 2026;158:158296. doi:10.1016/j.phymed.2026.158296
BibTeX
@article{Zhang2026,
author = {Zhang, Yi and Cao, Xianling and Ma, Yingjie and Guo, Zizhen and Lian, Fang and Song, Jingyan and Sun, Zhengao},
title = {Jiawei Shoutai Pill promotes embryo implantation via PPAR signaling and endometrial microbiota remodeling: An integrative multi-omics study},
journal = {Phytomedicine},
year = {2026},
volume = {158},
pages = {158296},
doi = {10.1016/j.phymed.2026.158296}
}
EUVIMED